Enforcement Report – Page 2 – CGMB Supplement Counsel

Category: Enforcement Report

Enforcement Report

FDA Warns Companies for Making Cancer Claims; Supplement Firm Recalls Products “tainted with anabolic steroids and steroid like substances”

FDA Warns Companies for Making Cancer Claims FDA recently sent 14 warning letters and 4 online advisory letters to companies, including dietary supplement marketers, for

May 12, 2017

Court Finds Against Hi-Tech Pharmaceuticals in DMAA Lawsuit: “[P]roducts . . . containing DMAA are adulterated”

By Rick Collins and David Torreblanca On April 3, the United States District Court for the Northern District of Georgia granted the Food and Drug

April 5, 2017

Enforcement Report

Department of Justice Enjoins Dietary Supplement Manufacturer’s Operations; FDA Issues Warning Letters over Alleged CGMP Violations

The latest top stories for the sports nutrition, dietary supplement, and cosmetics industries: Department of Justice Enjoins Dietary Supplement Manufacturer’s Operations Last month, the Department

February 10, 2017

Enforcement Report

FTC, NY AG Pursue Dietary Supplement Marketers for Allegedly Unsubstantiated Claims

On January 9, 2017, the Federal Trade Commission (“FTC”) and the New York State Attorney General (“NY AG”) charged the marketers of the dietary supplement

January 12, 2017

Enforcement Report

DEA Designates CBD a Schedule I Controlled Substance; FDA Publishes Adverse Event Report Data; Senator Calls for Stronger NDI Enforcement

Happy New Year! Last year ended with a bang, as DEA enacted a Final Rule to schedule marijuana extracts-including CBD-as controlled substances (see below). The

January 4, 2017

Enforcement Report

GNC to Ramp-Up Dietary Supplement Compliance Requirements; FDA Warns Company for Selling Sublingual Product as Supplement; FDA Says 1-Androsterone (1-DHEA) not a Dietary Ingredient

The latest top stories for the sports nutrition, dietary supplement, and cosmetics industries: GNC to Ramp-Up Dietary Supplement Compliance Requirements In the wake of a

December 12, 2016

Dietary Supplements

FDA Releases New Draft NDI Guidance; FDA Warns for Trade-Show Literature; President Signs GMO-Labeling Bill

The latest top stories for the sports nutrition / dietary supplement industry: FDA Releases New Draft New Dietary Ingredient Notification Guidance Today, FDA announced the

August 11, 2016

Dietary Supplements

Our firm is available 24 hours, 7 days a week for emergencies.

Fax: (516) 294-0477
Email: [email protected]

Address: 138 Mineola Blvd,
Mineola, NY 11501

Category: Enforcement Report

FDA Warns Companies for Making Cancer Claims; Supplement Firm Recalls Products “tainted with anabolic steroids and steroid like substances”

Court Finds Against Hi-Tech Pharmaceuticals in DMAA Lawsuit: “[P]roducts . . . containing DMAA are adulterated”

Department of Justice Enjoins Dietary Supplement Manufacturer’s Operations; FDA Issues Warning Letters over Alleged CGMP Violations

FTC, NY AG Pursue Dietary Supplement Marketers for Allegedly Unsubstantiated Claims

DEA Designates CBD a Schedule I Controlled Substance; FDA Publishes Adverse Event Report Data; Senator Calls for Stronger NDI Enforcement

GNC to Ramp-Up Dietary Supplement Compliance Requirements; FDA Warns Company for Selling Sublingual Product as Supplement; FDA Says 1-Androsterone (1-DHEA) not a Dietary Ingredient

FDA Releases New Draft NDI Guidance; FDA Warns for Trade-Show Literature; President Signs GMO-Labeling Bill

FDA Updates Nutrition and Supplement Facts Panels; Cosmetics Claims Under Increasing Scrutiny

FDA Warns CBD Products Are Not “Supplements”; Insurance Provider Exits Industry

FDA Targets cGMP Violations and Seizes Kratom Supplement

Categories

Our firm is available 24 hours, 7 days a week for emergencies.

Areas of Practice

Recent Post

Areas of Practice

Newsletter